Sabra Health Care REIT (NASDAQ:SBRA) Releases FY 2025 Earnings Guidance

Sabra Health Care REIT (NASDAQ:SBRA) updated its FY 2025 earnings guidance on Wednesday. The company provided earnings per share guidance of 1.430-1.460 for the period, compared to the consensus earnings per share estimate of 1.480. The company issued revenue guidance of -.

Sabra Health Care REIT Stock Performance

Sabra Health Care REIT stock traded up $0.09 during mid-day trading on Wednesday, reaching $16.55. The company had a trading volume of 2,383,460 shares, compared to its average volume of 2,028,608. The company has a quick ratio of 4.16, a current ratio of 4.16 and a debt-to-equity ratio of 0.90. The firm has a market cap of $3.92 billion, a price-to-earnings ratio of 40.37, a PEG ratio of 1.99 and a beta of 1.25. The company has a 50 day moving average of $16.92 and a 200-day moving average of $17.63. Sabra Health Care REIT has a 52 week low of $13.31 and a 52 week high of $20.03.

Sabra Health Care REIT (NASDAQ:SBRA) last released its earnings results on Wednesday, February 19th. The real estate investment trust reported $0.36 earnings per share for the quarter, meeting the consensus estimate of $0.36. Sabra Health Care REIT had a net margin of 14.20% and a return on equity of 3.51%. On average, sell-side analysts expect that Sabra Health Care REIT will post 1.39 EPS for the current fiscal year.

Sabra Health Care REIT Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, February 28th. Stockholders of record on Friday, February 14th will be paid a $0.30 dividend. The ex-dividend date is Friday, February 14th. This represents a $1.20 annualized dividend and a dividend yield of 7.25%. Sabra Health Care REIT’s dividend payout ratio is currently 292.69%.

Wall Street Analyst Weigh In

Several equities analysts recently issued reports on the stock. JMP Securities raised shares of Sabra Health Care REIT from a “market perform” rating to an “outperform” rating and set a $20.00 price target for the company in a report on Tuesday, January 7th. Citizens Jmp upgraded Sabra Health Care REIT from a “hold” rating to a “strong-buy” rating in a report on Tuesday, January 7th. Mizuho reiterated a “neutral” rating and set a $20.00 target price on shares of Sabra Health Care REIT in a research report on Thursday, December 5th. Finally, Truist Financial lowered shares of Sabra Health Care REIT from a “buy” rating to a “hold” rating and reduced their price objective for the stock from $18.00 to $17.00 in a research note on Friday, January 17th. Three equities research analysts have rated the stock with a hold rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, Sabra Health Care REIT has a consensus rating of “Moderate Buy” and a consensus price target of $18.86.

About Sabra Health Care REIT

Sabra Health Care REIT, Inc engages in the business of acquiring, financing, and owning real estate property. The company was founded on May 10, 2010 and is headquartered in Tustin, CA.